Skip to main content
SpringerLink
Log in

Vasodilator therapy of pulmonary hypertension in the crst syndrome

  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Summary

TWO patients with the CRST syndrome and pulmonary hypertension are described. They were treated with hydralazine given orally in a dosage of 200 mgs daily. One patient improved subjectively and had a better exercise capacity but the signs of pulmonary hypertension and tricuspid regurgitation persisted. The other patient has shown a marked clinical improvement and a significant reduction of the pulmonary hypertension has been demonstrated on repeat cardiac catheterisation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Camerini, F., Alberti, E., Klugmann, S. and Salvi, A. 1980. Primary pulmonary hypertension: Effects of nifedipine. Br. Heart J. 44, 352.

    Article  PubMed  CAS  Google Scholar 

  • Daoud, F. S., Reeves, J. T. and Kelly, D. 1978. Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. Am. J. Cardiol. 42, 817.

    Article  PubMed  CAS  Google Scholar 

  • Fahey, P. J., Utell, M. J., Condemi, J. J., Green, R. M. and Hyde, R. W. 1980. Raynaud’s phenomenon of the pulmonary vasculature. Chest 78, 515.

    Google Scholar 

  • Hall, D. R. and Petch, M. C. 1981. Remission of primary pulmonary hypertension during treatment with diazoxide. Br. Med. J. 282, 1118.

    CAS  Google Scholar 

  • Honey, M., Cotter, L., Davies, N., Denison, D. 1980. Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension. Thorax 35, 269.

    Article  PubMed  CAS  Google Scholar 

  • Howard, T. P., Solomon, D. A., Germain, B. and Goldman, A. L 1980. Clinically silent pulmonary hypertension in the CRST syndrome. Chest 78, 522.

    Article  Google Scholar 

  • Rubin, L. J., Peter, R. H. 1980. Oral hydralazine therapy for primary pulmonary hypertension. N. Eng. J. Med. 302, 69.

    CAS  Google Scholar 

  • Sackner, M. A., Akgun, N., Kimbel, P. and Lewis, D. H. 1964. The pathophysiology of scleroderma involving the heart and respiratory system. Ann. Int. Med. 60, 611.

    PubMed  CAS  Google Scholar 

  • Salerni, R., Rodnan, G. P., Leon, D. F. and Shaver, J. A. 1977. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann. Int. Med. 86, 394.

    PubMed  CAS  Google Scholar 

  • Shettigar, U. R., Hultgren, H. N., Specter, M., Martin, R. and Davies, D. H. 1976. Primary pulmonary hypertension favourable effect of isoproterenol. N. Eng. J. Med. 295, 1414.

    CAS  Google Scholar 

  • Velayos, E. E., Masi, A. T., Stevens, M. B. and Shulman, L. E. 1979. The ’CREST syndrome. Comparison with systemic sclerosis (scleroderma). Arch. Intern. Med. 139, 1240.

    Article  PubMed  CAS  Google Scholar 

  • Wang, S. W. S., Pohl, J. E. F., Rowlands, D. J. and Wade, E. G. 1978. Diazoxide in treatment of primary pulmonary hypertension. Br. Heart J. 40, 572.

    Article  PubMed  CAS  Google Scholar 

  • Winterbauer, R. H. 1964. Multiple telangiectasia, Raynaud’s phenomenon, sclerodactyly and subcutaneous calcinosis: A syndrome mimicking hereditary hemorrhagic telangiectasia. Bull. Johns Hopkins Hosp. 114, 361.

    PubMed  CAS  Google Scholar 

  • Young, R. H. and Mark, G. J. 1978. Pulmonary vascular changes in scleroderma. Am. Med. J. 64, 998.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Regional Hospital, Galway

    J. McWeeney & P. Finnegan

Authors
  1. J. McWeeney
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Finnegan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McWeeney, J., Finnegan, P. Vasodilator therapy of pulmonary hypertension in the crst syndrome. Ir J Med Sci 151, 151–154 (1982). https://doi.org/10.1007/BF02940166

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02940166

Keywords

Search

Navigation